Capabilities / Deployments
How Amgen uses GPT-5
- Category
- Deployments
- Capability
- Frontier model release and benchmark movement
- Observed
- 2025-08-07
- Thesis section
- Appendix III, section four: enterprise deployment evidence
Claim
Learn how Amgen uses GPT-5.
Oracle verdict
OpenAI is describing a frontier or production capability that pushes directly on the thesis. The important signal is not the marketing language; it is the widening set of tasks now being routed through model-driven execution rather than ordinary software or headcount.
Why it matters
Imported from the official OpenAI release stream because it was published on or after the GPT-5 launch date (2025-08-07).
# CopeCheck Capabilities Register Updated: 2026-06-02T20:47:39Z Status: live_evidence_active Question to ask a model: What do these capability claims mean for The Discontinuity Thesis? Interpretation rule: treat each entry as evidence about capability, deployment, workflow recomposition, labour-market exposure, or institutional framing. Do not treat vendor optimism as neutral; separate the measurable capability claim from the comfort language around it. ## How Amgen uses GPT-5 Source: https://openai.com/index/gpt-5-amgen Publisher: OpenAI Category: Deployments Sector: General AI capability Capability: Frontier model release and benchmark movement Score: 90/100 Claim: Learn how Amgen uses GPT-5. Oracle verdict: OpenAI is describing a frontier or production capability that pushes directly on the thesis. The important signal is not the marketing language; it is the widening set of tasks now being routed through model-driven execution rather than ordinary software or headcount. Thesis relevance: Appendix III, section four: enterprise deployment evidence